New and innovative technologies in the time of COVID-19

Over the past 12 months, Menarini Diagnostics has brought to market a range of new and innovative technologies to aid in the global fight against Covid-19. The company is now pleased to support this week’s BSMT webinar series on COVID-19.

COVID-19: proceedings on Day 1 of the BSMT webinar

This British Society for Microbial Technology (BSMT) webinar series of lectures is recorded, so registrants can view either in real time or after the event when convenient to do so.

Common laboratory tests for hospitalised COVID-19 patients

The VITROS COVID-19 Total and IgG Antibody Tests and VITROS SARS-CoV-2 Antigen Test from Ortho Clinical Diagnostics help to identify an active or previous infection, together with PCR and clinical history.

Cases of human-to-cat SARS-CoV-2 transmission identified in the UK

A team of scientists at the University of Glasgow has identified two known cases of human-to-cat SARS-CoV-2 transmission in the UK.

SARS-CoV-2 neutralisation assay development kit launched

The Native Antigen Company has launched its SARS-CoV-2 Neutralisation Assay Development Kit, which can be used to identify and qualitatively assess the ability of antibodies to neutralise SARS-CoV-2-receptor binding.

Launch of SARS-CoV-2 Variant RT-PCR assays announced

Bio-Rad Laboratories has launched the SARS-CoV-2 Variant RT-PCR assays, which can detect the variants of concern, including P.1, B.1.351, and B.1.1.7.

Antigen detection of SARS-CoV-2 variants

All ViroStat COVID-19 monoclonal antibodies are validated to react with the nucleocapsid of common variants circulating, including UK B.1.1.7, South Africa B.1.351 and Brazil P.1, ensuring that the variants will be detected with these antibodies.

Foundation for SARS-CoV-2 inhibitors discovery

A new international study has provided a template for how to develop directly-acting antivirals with novel modes of action, that would combat COVID-19 by suppressing the SARS-CoV-2 viral infection.

Final speaker confirmed for BSMT Virtual Conference on COVID-19

The BSMT has confirmed that Professor Sheena Cruikshank (University of Manchester) will speak on 'From Variola to COVID-19: the Development of Modern Vaccines'. Click on this news item for the link to register for this FREE-to-attend webinar series.

Register now for the BSMT Virtual Conference on COVID-19

The British Society for Microbial Technology event takes place on Tuesday 11 May to Friday 14 May 2021. Click on this news item for the link to register for this FREE-to-attend webinar series.

Rapid antigen self-test selected by NIH for RADx initiative funding

Mologic, a developer of lateral-flow and rapid diagnostics, has announced its rapid antigen self-test for SARS-CoV-2 has been selected by the Rapid Acceleration of Diagnostics (RADx) initiative launched by the US National Institutes of Health (NIH).

Global distribution agreement for SARS-CoV-2 research ELISA reagents

Avacta Group, the developer of cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms, has announced a global distribution agreement with ABCAM to sell the SARS-CoV-2 research ELISA Affimer reagents.

COVID-19: BSMT Virtual Conference in May – REGISTRATION now open

The BSMT Virtual Conference on COVID-19 is a FREE-to-attend event that takes place on Tuesday 11 May to Friday 14 May 2021. Click on this news item for the link to register for the webinar series.

Enhance COVID-19 diagnostic testing solution announced

Thermo Fisher Scientific and Artificial, a developer of flexible automation software, have announced a technology collaboration to develop an integrated and comprehensive software platform for Thermo Fisher’s standardised COVID-19 Testing Platform.

COVID-19: The Infection Challenging the World – BSMT sponsor update

This British Society for Microbial Technology (BSMT) virtual conference, held in conjunction with media partner Pathology in Practice, on 11–14 May, will be sponsored by 22 companies.

Novel SARS-CoV-2 neutralising antibodies identified

IONTAS and FairJourney Biologics have announced the identification of neutralising antibodies, which bind to multiple emerging SARS-CoV-2 variants.

Interleukin-6 test now available to help identify severe COVID-19

Beckman Coulter today has expanded claims for its CE-marked Access Interleukin-6 (IL-6) assay, an in vitro diagnostic test for the quantitative determination of IL-6 levels in human serum and plasma.

Commercial partnership to develop SARS-CoV-2 rapid antigen test

Aptamer Group, the developer of diagnostic and therapeutic Optimer reagents, has announced a commercial partnership with Mologic, a developer and manufacturer of lateral-flow and rapid diagnostic tests.

COVID-19: The Infection Challenging the World – BSMT programme update

Additions to the programme and sponsors for this important British Society for Microbial Technology (BSMT) virtual conference, which will be held on 11–14 May, have now been released. See the following for the latest details…

A new face for the BSMT, and a virtual meeting in May

The British Society for Microbial Technology (BSMT) will hold a virtual conference entitled ‘COVID-19 – The Infection Challenging the World' over four days in May. Click on this story for current details of the programme and commercial support.

Latest Issues

The Power to Disrupt - Clinical Diagnostics Expo UK

15 Hatfields
16 September, 2024

Microbe Conference 2024

Crowne Plaza Hotel, Sheffield, UK
20-22 September, 2024

Cardiac Marker Dialogues: Cardiac Biomarkers in Real Time – Experiences and Opportunities

Hilton Glasgow, 1 William Street, Glasgow, Scotland, G3 8HT
26-27 September, 2024

The British Association for Cytopathology Annual Scientific Meeting

Aztec Hotel and Spa, Bristol, BS32 4TS
18 October, 2024

UK NEQAS: Navigating Quality Standards in Point of Care Testing

The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024